JOIMEMVI
Dead / Abandoned — Abandoned — failure to respond (as of 01 Apr 2025)
What this means for you
This application is over — abandoned 05 Mar 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97860538
- Mark type
- Stylized text
- Filed
- 28 Mar 2023
- Abandoned
- 05 Mar 2025
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, pharmaceutical preparations and pharmaceutical agents; pharmaceuticals in the nature of small molecule chemical compounds; pharmaceuticals for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical agents for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis
Owner
- Athira Pharma, Inc., Bothell, WA, US
Prosecution history
- 01 Apr 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Apr 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 04 Dec 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 04 Dec 2024 — FINAL REFUSAL E-MAILED
- 04 Dec 2024 — FINAL REFUSAL WRITTEN
- 25 Oct 2024 — ASSIGNED TO EXAMINER
- 16 Jul 2024 — ASSIGNED TO EXAMINER
- 03 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Jan 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 26 Jan 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 10 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Jan 2024 — NON-FINAL ACTION E-MAILED
- 10 Jan 2024 — NON-FINAL ACTION WRITTEN